Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AAAP

Advanced Accelerator

$67.13

0.39 (0.58%)

, KURA

Kura Oncology

$14.35

0.4 (2.87%)

08:30
10/12/17
10/12
08:30
10/12/17
08:30
Options
Four new option listings on October 12th »

New option listings for…

AAAP

Advanced Accelerator

$67.13

0.39 (0.58%)

KURA

Kura Oncology

$14.35

0.4 (2.87%)

NBRV

Nabriva Therapeutics

$8.11

-0.11 (-1.34%)

WTTR

Select Energy Services

$15.64

0.37 (2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

Over a week ago
NBRV

Nabriva Therapeutics

$9.19

0.32 (3.61%)

05:59
09/20/17
09/20
05:59
09/20/17
05:59
Syndicate
Nabriva Therapeutics 9.41M share Secondary priced at $8.50 »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 20

    Sep

SCS

Steelcase

$14.35

0.1 (0.70%)

, DRNA

Dicerna

$3.99

0.08 (2.05%)

17:31
09/18/17
09/18
17:31
09/18/17
17:31
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SCS

Steelcase

$14.35

0.1 (0.70%)

DRNA

Dicerna

$3.99

0.08 (2.05%)

NBRV

Nabriva Therapeutics

$8.87

2.01 (29.30%)

SUPN

Supernus

$49.65

0.6 (1.22%)

BECN

Beacon Roofing

$49.24

0.56 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 19

    Sep

  • 25

    Sep

  • 25

    Oct

  • 26

    Oct

  • 20

    Sep

  • 21

    Sep

NBRV

Nabriva Therapeutics

$8.87

2.01 (29.30%)

16:06
09/18/17
09/18
16:06
09/18/17
16:06
Syndicate
Nabriva Therapeutics files to sell $80M in common stock »

Morgan Stanley and BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 25

    Sep

NBRV

Nabriva Therapeutics

13:15
09/18/17
09/18
13:15
09/18/17
13:15
Recommendations
Nabriva Therapeutics analyst commentary at SunTrust »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 25

    Sep

NBRV

Nabriva Therapeutics

$6.86

-1.62 (-19.10%)

12:32
09/18/17
09/18
12:32
09/18/17
12:32
Recommendations
Nabriva Therapeutics analyst commentary at Wedbush »

Wedbush calls Nabriva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 25

    Sep

NBRV

Nabriva Therapeutics

$6.86

-1.62 (-19.10%)

11:31
09/18/17
09/18
11:31
09/18/17
11:31
Recommendations
Nabriva Therapeutics analyst commentary at Leerink »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 25

    Sep

NBRV

Nabriva Therapeutics

$6.86

-1.62 (-19.10%)

08:01
09/18/17
09/18
08:01
09/18/17
08:01
Conference/Events
Nabriva Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 25

    Sep

NBRV

Nabriva Therapeutics

$6.86

-1.62 (-19.10%)

07:23
09/18/17
09/18
07:23
09/18/17
07:23
Hot Stocks
Nabriva Therapeutics announces topline results from LEAP 1 trial »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Over a month ago
NBRV

Nabriva Therapeutics

$8.48

-0.02 (-0.24%)

09:25
09/15/17
09/15
09:25
09/15/17
09:25
Conference/Events
Nabriva Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.